BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study. World J Gastroenterol 2017; 23(4): 629-637 [PMID: 28216969 DOI: 10.3748/wjg.v23.i4.629]
URL: https://www.wjgnet.com/1948-5182/full/v23/i4/629.htm
Number Citing Articles
1
Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari, C. E. Eapen, Guohong Han, Hemant Deshmukh, Ian Homer Y. Cua, Cosmas Rinaldi Adithya Lesmana, Mamun Al Meshtab, Masayoshi Kage, Roongruedee Chaiteeraki, Sombat Treeprasertsuk, Suprabhat Giri, Sundeep Punamiya, Valerie Paradis, Xingshun Qi, Yasuhiko Sugawara, Zaigham Abbas, Shiv Kumar Sarin. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Hepatology International 2021; 15(3): 531 doi: 10.1007/s12072-021-10189-4
2
Lina I. Arcila-Garcés, José D. Correa-Vargas, Camila Guerrero-Bermúdez, Mariana Vélez-Marín. Manejo de pacientes con síndrome de Budd-Chiari. Revisión de temaHepatología 2020; : 55 doi: 10.52784/27112330.115
3
Aboelyazid Elkilany, Mohamed Alwarraky, Timm Denecke, Dominik Geisel. Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomesScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16818-8
4
Ayşe Erden, Diğdem Kuru Öz, Mehmet Adıgüzel, Funda Seher Özalp Ateş. Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndromeDiagnostic and Interventional Radiology 2023; 29(3): 428 doi: 10.4274/dir.2022.221462
5
Subrat Kumar Acharya, Sawan Bopanna. Budd-Chiari Syndrome2020; : 189 doi: 10.1007/978-981-32-9232-1_15
6
Dhiraj Agrawal, Deepak Gupta, Rohit Nathani, Prashant Dhore, Megha Meshram, Shobna J. Bhatia, Akash Shukla. Presence of Ascites at Presentation is Associated With Absence of Long-Term Response Amongst Patients With Budd-Chiari Syndrome When Treated With Medical Therapy Alone: A Single Centre Real-Life ExperienceJournal of Clinical and Experimental Hepatology 2022; 12(3): 861 doi: 10.1016/j.jceh.2021.10.148
7
Paul J. Thuluvath, Joseph J. Alukal, Talan Zhang. A Scoring Model to Predict In-Hospital Mortality in Patients With Budd–Chiari SyndromeAmerican Journal of Gastroenterology 2021; 116(9): 1905 doi: 10.14309/ajg.0000000000001273
8
Justin R. Boike, Bartley G. Thornburg, Sumeet K. Asrani, Michael B. Fallon, Brett E. Fortune, Manhal J. Izzy, Elizabeth C. Verna, Juan G. Abraldes, Andrew S. Allegretti, Jasmohan S. Bajaj, Scott W. Biggins, Michael D. Darcy, Maryjane A. Farr, Khashayar Farsad, Guadalupe Garcia-Tsao, Shelley A. Hall, Caroline C. Jadlowiec, Michael J. Krowka, Jeanne Laberge, Edward W. Lee, David C. Mulligan, Mitra K. Nadim, Patrick G. Northup, Riad Salem, Joseph J. Shatzel, Cathryn J. Shaw, Douglas A. Simonetto, Jonathan Susman, K. Pallav Kolli, Lisa B. VanWagner. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal HypertensionClinical Gastroenterology and Hepatology 2022; 20(8): 1636 doi: 10.1016/j.cgh.2021.07.018
9
Elton Dajti, Federico Ravaioli, Antonio Colecchia, Giovanni Marasco, Amanda Vestito, Davide Festi. Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari SyndromeCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/1673197